November 21, 2012 By Leave a Comment
In light of the recent national fungal meningitis outbreak traced back to the New England Compounding Center (NECC), Senators Richard Blumenthal (D-Conn.), Debbie Stabenow (D-Mich.), Al Franken (D-Minn.), and Dianne Feinstein (D-Calif.) are asking CMS for information about its procedures with respect to reimbursement for compounded drugs. The senators issued a letter asking CMS how it determines whether drugs are created by compounding pharmacies found to be in violation of the Food, Drug, and Cosmetic Act (FDCA). The senators also sought information about coordination between CMS and the Food and Drug Administration (FDA).
Continue Reading here
No comments:
Post a Comment